CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-02). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2002 · Search date 2026-08-02 · Methodology v0.6

One whole Brazil nut daily,
does it really help with Improved cognition in mild cognitive impairment?

30-Second Summary
C
Evidence Grade C · 44 · Safety caution
The cognitive signal for one Brazil nut daily rests on a pilot analysis of only 20 completers
Brazil nuts can cause tree-nut allergy and their selenium content varies widely. Chronic excess can cause hair loss, nail changes, and garlic odor on the breath, so daily use with selenium supplements warrants particular caution.
What the
research shows
The grade is C with 44 points. A pilot trial randomized 31 people with mild cognitive impairment but analyzed only 20 completers. At six months, verbal fluency gave p=0.007 and constructional praxis p=0.031, with approximate effect sizes of 1.3 and 1.0.
What the
ads claim
High selenium content cannot be converted directly into better memory or cognition. Positive findings on selected subtests in a small pilot are not confirmation.
*

Useful facts when choosing a product

  • A typical Brazil nut contains about 68 to 91 micrograms of selenium, enough to exceed the adult recommended intake of about 55 micrograms with one nut.
  • The trial nut was estimated at about 288.75 micrograms of selenium per nut, distinctly above the general range. The adult upper intake level is 400 micrograms daily, and other foods or supplements can add to exposure.
  • Brazil nuts originate in South America, so absence from East Asian classical texts is expected. No unverified passage is quoted.
  • Verdict 258 is C with 44 points for isolated sesamin, verdict 226 is C with 43 points for pumpkin-seed oil, and verdict 062 is A with 84 points for psyllium husk. These isolated constituents, oil, and husk are not a whole Brazil nut.
Gap Measurement · Verdict 2002 · C 44
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The 2016 European Journal of Nutrition paper by Cardoso and colleagues and its PubMed record were checked. The exact original funding statement still requires confirmation from the full paper, and no producer-board or food-company support was confirmed. Industry funding was not inferred from affiliations.

02

Why this is classified as C (44)

Selected cognitive tests had large approximate effects, but they were back-calculated from P values rather than reported directly. This single pilot analyzed only 20 of 31 randomized participants and assessed multiple subtests, yielding C with 44 points.

Counterpoint. A sufficiently powered independent trial with one prospectively registered primary cognitive outcome is needed.

Rejudgment record. Cross-check applied — Original-report and PubMed data cross-checked with authoritative selenium guidance to separate analyzed sample, multiple subtests, approximate P-value-derived effects, trial-nut selenium, and general composition

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE+Meets the clinically important threshold
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
One Brazil nut contains a very large amount of selenium?This is a composition fact, not a graded clinical outcome.
One whole Brazil nut daily improves cognition in mild cognitive impairmentCOnly selected subtests were positive in a small completer analysis.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Six-month randomized controlled pilot with completer analysis9Exact original funding wording requires confirmation; no confirmed producer-board or food-company supportMultiple CERAD cognitive subtestsVerbal fluency p=0.007 and constructional praxis p=0.031; approximate P-value-derived effects 1.3 and 1.0Large approximate effects but unstable because of attrition, multiplicity, and small sample
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-08-02).

Cardoso BR, et al. Effects of Brazil nut consumption on selenium status and cognitive performance in older adults with mild cognitive impairment. Eur J Nutr. 2016;55:107-116. DOI: 10.1007/s00394-014-0829-2.
checked
NIH Office of Dietary Supplements. Selenium: Fact Sheet for Health Professionals.
checked
Cardoso BR, et al. Effects of Regular Brazil Nut Consumption on Health: A Systematic Review of Clinical Trials. Foods. 2022;11:2925. DOI: 10.3390/foods11182925.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-02 · Corrections: none

Cite this verdict

One whole Brazil nut daily x cognition in mild cognitive impairment Evidence Grade C card
[Chamgap] One whole Brazil nut daily x cognition in mild cognitive impairment — Evidence Grade C·44. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/cognition/whole-brazil-nut-mild-cognitive-impairment/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.